Coronavirus updates: In 2020, vaccine maker Novovax Inc had announced a license agreement with the Covishield maker-Serum Institute of India (SII) for the development and commercialisation of its Covid-19 vaccine candidate NVX-CoV2373, or Covovax.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.